Mednet Logo
HomePrimary CareQuestion

How would you manage a middle-aged patient with Paget's disease who received one dose of zolendronic acid 2 years ago, currently suppressed CTX, normal bone-specific Alkaline phos, and a recent hairline fracture in the thoracic spine?

2 Answers
Mednet Member
Mednet Member
Rheumatology · NYU Langone

Parathyroid hormone analogs are, of course, contraindicated in patients with Paget's disease and I am not aware of any data regarding the use of romosozumab in patients with this condition. Paget's disease is primarily considered to be an osteoclast-related disorder and bisphosphonates, particularly...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

I am not aware of any data on using anabolics in patients with Paget’s disease of the bone. With the theoretical concern of osteosarcoma, it was part of the label for tptd and abaloparatide to not give PTH anabolics to patients with Paget’s. Since there was a theoretical baseline increase in osteosa...

Register or Sign In to see full answer

How would you manage a middle-aged patient with Paget's disease who received one dose of zolendronic acid 2 years ago, currently suppressed CTX, normal bone-specific Alkaline phos, and a recent hairline fracture in the thoracic spine? | Mednet